The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia

NCT04314271 | Unknown

• 1 other identifier: 202003028
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Complete the examination of cardio-pulmonary ultrasound in accordance with the a-ccue process of patients with novel coronavirus bedside. To summarize and analyze the characteristics of cardiopulmonary ultrasound in patients with novel coronavirus pneumonia, and assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis. Auto line B is a method which is based on artificial intelligence is used to calculate the lungs ultrasonic B line numbers reviewing the status of patients with lung, and also evaluate patients' lungs using the traditional artificial semi-quantitative method, to evaluate those two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not, and verify consistency of ultrasonic evaluation method and the way of CT evaluation.

Conditions

Novel Coronavirus Pneumonia

Outcome Measures

Primary Outcomes (1)

• characteristics of cardiopulmonary ultrasound

  Complete the examination of cardio-pulmonary ultrasound in accordance with the a-ccue process of patients with novel coronavirus bedside. To summarize and analyze the characteristics of cardiopulmonary ultrasound in patients with novel coronavirus pneumonia

  30 mins

Secondary Outcomes (1)

• assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis.

  2-3weeks

Other Outcomes (1)

• evaluate two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not, and verify consistency of ultrasonic evaluation method and the way of CT evaluation.

  3 hours

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adult (Age ≥ 18 years) patients with novel coronavirus pneumonia

You may qualify if:

• age \>18 years old
• identify the patients infected with novel coronavirus pneumonia;
• the patient completed CT examination;
• sign the informed consent.

You may not qualify if:

• age \< 18;
• those who cannot complete cardiopulmonary ultrasound according to the a-ccue process;
• the patient or his guardian requests to withdraw from the researcher;

Sponsors & Collaborators

• Xiangya Hospital of Central South University: lead

Study Sites (1)

Xiangya Hospital, Central South University

Changsha, Hunan, 410000, China

RECRUITING

Study Officials

• Zhang Li Na, MD

  Xiangya Hospital

  STUDY CHAIR

Central Study Contacts

Zhao Ch Guang, MD

CONTACT

+86136673520046; 562122649@qq.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Weeks
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 16, 2020
• First Posted: March 19, 2020
• Study Start: March 20, 2020
• Primary Completion: May 1, 2020
• Study Completion: May 31, 2020
• Last Updated: March 19, 2020

Record last verified: 2020-03

Locations

CN (1)